SUN-101

glycopyrrolate · Sunovion Pharmaceuticals

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for SUN-101, covering 2018-01-25 to 2018-03-22. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD [Phase 3]